Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295965
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2024-02-06
Brief Title:
Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers CHANCES Study
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers CHANCES
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancers Researchers want to identify risk factors for developing these blood cancers as well as if there isare a geneticenvironmental components to developing blood cancer
Detailed Description:
OUTLINE This is an observational study
Patients undergo blood sample collection and complete surveys on study Patients medical records are also reviewed
Patients undergo blood sample collection and complete surveys on study Patients medical records are also reviewed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2023-10315 | REGISTRY | None | None |
| FHIRB0020162 | OTHER | None | None |
| R01CA272594 | NIH | Fred HutchUniversity of Washington Cancer Consortium | httpsreporternihgovquickSearchR01CA272594 |